Meet Pharmidex at KTN 2016
June 14, 2016

Collaboration opportunities in regenerative medicine

Pharmdiex will be attending the Innvoate UK KTN 2016 meeting focused on New Collaboration Opportunities in Regenerative Medicine.

The KTN in collaboration with Innovate UK, Cell and Gene Therapy Catapult, Department of Health and Kings College London are holding an event focussing on new unmet clinical needs, latest developments in regulatory environment and clinical adoption. Following recent developments and the UK’s Regenerative Medicine Expert Group report recommendations, this event will bring together the UK regenerative medicine communities involving industrialists, academics and clinicians from a number of clinical specialities.


The UK is leading the field in the development of cell and gene therapies. The regulatory system now has a number of mechanisms to accelerate the progress of promising therapies including EAMS and the proposed new PRIME scheme. However, practical challenges still exist to the clinical adoption of these new therapies and getting them to patients, including generating sufficient clinical data, achieving reimbursement and embedding therapies in existing or new clinical pathways).


Leading clinicians and experts from a number of organisations will be presenting at this event. Directors and managers from major funding organisations, e.g. Innovate UK, Research Councils, relevant charities will also be invited to support this event.


The main aims of this event are as follows;


  • To discuss challenges affecting clinical adoption of cell and gene-based therapies.
  • Facilitate new clinician/industry collaborations in a number of areas of clinical specialities.
  • Identify barriers to innovation and commercialisation.
  • Review current funding opportunities and identify funding gaps.
  • Provide networking opportunities to identify collaborating partners.
  • Review supporting mechanisms available to accelerate innovation and commercialisation through KTN and partners Innovate UK, Cell and Gene Therapy Catapult organisations.
  • Review current pre-clinical and clinical trials and identify best practice to accelerate regulatory approvals


For more information please see the following link: https://www.eventbrite.co.uk/e/new-collaboration-opportunities-in-regenerative-medicine-tickets-24454460951

📢 Welcome to Pharmidex, Ty Hoffmann!

June 25, 2026
We are pleased to welcome Ty Hoffmann to Pharmidex as our new Business Development Associate (US). Ty recently graduated from Fisher College with a Bachelor’s degree in Cybersecurity and joins us with experience in sales, business development, and client engagement. His background combines commercial awareness with strong analytical and technical skills, making him a great addition to our growing team. As Pharmidex continues to expand its presence across North America, Ty will focus on building new client relationships and supporting organisations seeking high-quality preclinical drug discovery and development services. We are excited to have Ty on board and look forward to supporting his growth and success within the business. Please join us in welcoming him to the Pharmidex team!

Pharmidex team members runs the St Albans Summer Solstice 10K!

June 23, 2026
🏃‍♂️☀️ Congratulations to our Pharmidex team members who took part in the St Albans Summer Solstice 10K #BeatTheSunset ! It was great to see colleagues enjoying a fantastic summer evening while supporting their physical and mental wellbeing. At Pharmidex , we believe health extends beyond the laboratory and activities like these are a great way to stay active, connect with colleagues and have fun. Well done to everyone who took part and represented Pharmidex so positively!

Thanks to our interns from City St George’s, University of London

June 19, 2026
A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.
More Posts